New hope for PBC patients: drug targets debilitating itch
NCT ID NCT06733519
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 32 times
Summary
This study tests a new medicine called TH104 for people with primary biliary cholangitis (PBC) who suffer from moderate to severe itching. About 40 adults will receive either TH104 or a placebo to see if the drug is safe and helps reduce itch. The goal is to improve quality of life by easing this distressing symptom.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.